CN111533718A - Method for preparing benzbromarone - Google Patents

Method for preparing benzbromarone Download PDF

Info

Publication number
CN111533718A
CN111533718A CN202010397997.4A CN202010397997A CN111533718A CN 111533718 A CN111533718 A CN 111533718A CN 202010397997 A CN202010397997 A CN 202010397997A CN 111533718 A CN111533718 A CN 111533718A
Authority
CN
China
Prior art keywords
compound
stirring
reaction
dichloromethane
benzbromarone
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN202010397997.4A
Other languages
Chinese (zh)
Other versions
CN111533718B (en
Inventor
赵旭
杨甫余
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Zhejiang Haizhou Pharmaceutical Co ltd
Original Assignee
Zhejiang Haizhou Pharmaceutical Co ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zhejiang Haizhou Pharmaceutical Co ltd filed Critical Zhejiang Haizhou Pharmaceutical Co ltd
Priority to CN202010397997.4A priority Critical patent/CN111533718B/en
Publication of CN111533718A publication Critical patent/CN111533718A/en
Application granted granted Critical
Publication of CN111533718B publication Critical patent/CN111533718B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78Benzo [b] furans; Hydrogenated benzo [b] furans
    • C07D307/79Benzo [b] furans; Hydrogenated benzo [b] furans with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • C07D307/80Radicals substituted by oxygen atoms
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Abstract

The invention discloses a method for preparing benzbromarone, which takes 3, 5-dibromo-4-hydroxybenzoic acid as a raw material and dihydropyran as a hydroxyl protection reagent to prepare benzbromarone, and the hydroxyl protection and the hydroxyl deprotection of dihydropyran are realized through the explored optimized process conditions, so that the aims of reducing the generation of byproducts in the reaction process, improving the yield and reducing the cost are fulfilled.

Description

Method for preparing benzbromarone
Technical Field
The invention relates to the technical field of compound preparation, in particular to a method for preparing benzbromarone.
Background
Chemical name: (3,5-dibromo-4-hydroxyphenyl) (2-ethyl-3-benzofuranyl) one
The name of English: (3, 5-dibromo-4-hydroxypropylenyl) (2-ethyl-3-benzofuranyl) keton
Structural formula (xvi):
Figure BDA0002488289550000011
the molecular formula is as follows: c17H12Br2O3
Molecular weight: 424
Benzbromarone is also known as bromobenzoyl benzofuran, and benzbromarone is a strong uric acid-removing benzofuran derivative and has a strong uric acid-removing effect. The compound can effectively inhibit reabsorption of renal tubules on uric acid, promote excretion of uric acid, and has dual functions of reducing blood uric acid concentration.
US20190218243 and CN201310191043.8 describe a synthesis method of related intermediates or benzbromarone, which all adopt 3, 5-dibromo-4-hydroxybenzoic acid to undergo acetylation protection, then undergo an acyl chlorination reaction, undergo a friedel-crafts acylation reaction with 2-ethylbenzofuran, and undergo hydrolysis to obtain benzbromarone. During the experimental pilot preparation process, the following problems are found to easily occur through the above documents:
1. during the acetylation protection, a byproduct of the acetylation of the carboxyl group is inevitably generated, so that the subsequent reaction cannot be smoothly carried out.
2. The acetylation protects an ester group structure formed by hydroxyl groups, so that the hydrolysis is easy, and the subsequent acylation reaction generates hydroxyl chlorination and other byproducts.
Disclosure of Invention
The invention aims to provide a method for preparing benzbromarone, which solves the defects of the prior art.
The invention adopts the following technical scheme:
a method for preparing benzbromarone comprises the following steps:
Figure BDA0002488289550000021
further, the protective agent and the solvent for preparing the compound II by the compound I are dihydropyrane.
Further, the catalyst for preparing the compound IV from the compound III is aluminum trichloride.
Further, the solvent for preparing the compound V from the compound IV is ethanol, the catalyst is pyridine p-toluenesulfonate, and the reaction temperature is 50 ℃ to reflux.
Further, taking a compound I3, 5-dibromo-4-hydroxybenzoic acid as a raw material, adding a small amount of aluminum phosphate as a catalyst in an environment with dihydropyrane as a solvent and a protective agent, heating to reflux, stirring for reacting for 3 hours, performing suction filtration, and evaporating excessive dihydropyrane to obtain an oily compound II;
then adding dichloromethane into the compound II for dissolving, adding a small amount of dimethylformamide as a catalyst, adding N, N-diisopropylethylamine as an acid-binding agent, dropwise adding thionyl chloride at the temperature of not more than 25 ℃, keeping the temperature of 30-35 ℃ after dropwise adding, stirring for reaction, filtering, evaporating dichloromethane and excessive thionyl chloride to dryness, and purifying to obtain a compound III;
then dissolving the compound III in dichloromethane, adding 2-ethylbenzofuran, adding aluminum trichloride at-5-0 ℃, and carrying out Friedel-crafts acylation reaction and post-treatment to obtain a compound IV;
and then adding the compound IV into ethanol, adding pyridine p-toluenesulfonate as a catalyst, carrying out reflux stirring reaction at 50 ℃ for 3 hours, and carrying out aftertreatment to obtain a compound V.
Further, the method specifically comprises the following steps:
1) preparation of compound II from compound I
Adding 200ml of dihydropyrane, 10g of 3, 5-dibromo-4-hydroxybenzoic acid and 3g of aluminum phosphate into a 500ml reaction bottle, heating to reflux, stirring for reaction for 3 hours, cooling to room temperature, filtering off solid aluminum phosphate, distilling off excessive dihydropyrane under reduced pressure of 0.01MPa to obtain 12.16g of an oily compound II, wherein the yield is 95%, and no raw material point exists on a TLC point plate;
2) preparation of compound III from compound II
Adding 12g of the product obtained in the step 1) into a 500ml reaction bottle, adding 200ml of dichloromethane, 1 drop of dimethylformamide, 8.17g of N, N-diisopropylethylamine, stirring at 15-20 ℃ for 30min, then dropwise adding 7.5g of thionyl chloride, controlling the dropwise adding speed to be not more than 25 ℃, after dropwise adding is completed, keeping the temperature at 30-35 ℃ and stirring for reaction for 5h, filtering out hydrochloride of the N, N-diisopropylethylamine, evaporating dichloromethane and excessive thionyl chloride under reduced pressure at 30 ℃ to obtain an oily substance, adding 100ml of dichloromethane for dissolving, adding 100ml of saturated sodium chloride solution for washing and extracting, dehydrating an organic layer by using anhydrous magnesium sulfate, evaporating to obtain 12.1g of an oily compound III, wherein the yield is 96%, and the purity is 95% by HPLC (high performance liquid chromatography);
3) preparation of Compound IV from Compound III
Adding 12g of the compound III prepared in the step 2) into a 500ml dry reaction bottle, adding 200ml of dichloromethane, adding 5.3g of 2-ethyl-3-benzofuran, cooling to-5 ℃, stirring for 30min, adding 10g of aluminum trichloride, stirring for reacting for 5h, slowly dropwise adding 100ml of ice water, controlling the internal temperature to be not more than 5 ℃, standing for layering after dropwise adding is finished, removing a water layer, washing an organic layer twice by using 100ml of saturated sodium chloride solution, adding anhydrous magnesium sulfate into the organic layer for dehydration, and evaporating to dryness to obtain an oily compound IV14g, wherein the yield is 91.5%, and the purity is 96% by HPLC (high performance liquid chromatography) detection;
4) preparation of Compound V from Compound IV
Adding 14g of the compound IV obtained in the step 3) into a 500ml reaction bottle, adding 300ml of ethanol and 1g of pyridine p-toluenesulfonate, heating to 50 ℃, stirring for reaction for 3 hours, reducing the pressure to 50 ℃, evaporating the solvent to dryness to obtain an oily substance, adding 100ml of dichloroethane, heating to reflux for dissolution, cooling to 10 ℃, stirring for crystallization for 12 hours to obtain a compound V, namely 9.4g of a target product, namely a crude product of benzbromarone, wherein the yield is 80.34%, and the purity is 98% by HPLC (high performance liquid chromatography).
Further, the method specifically comprises the following steps:
1) preparation of compound II from compound I
Adding 200ml of dihydropyrane, 10g of 3, 5-dibromo-4-hydroxybenzoic acid and 3g of aluminum phosphate into a 500ml reaction bottle, heating to reflux, stirring for reaction for 3 hours, cooling to room temperature, filtering off solid aluminum phosphate, distilling off excessive dihydropyrane under reduced pressure of 0.01MPa to obtain 12.16g of an oily compound II, wherein the yield is 95%, and no raw material point exists on a TLC point plate;
2) preparation of compound III from compound II
Adding 12g of the product obtained in the step 1) into a 500ml reaction bottle, adding 200ml of dichloromethane, 1 drop of dimethylformamide, 8.17g of N, N-diisopropylethylamine, stirring at 15-20 ℃ for 30min, then dropwise adding 7.5g of thionyl chloride, controlling the dropwise adding speed to be not more than 25 ℃, after dropwise adding is completed, keeping the temperature at 30-35 ℃ and stirring for reaction for 5h, filtering out hydrochloride of the N, N-diisopropylethylamine, evaporating dichloromethane and excessive thionyl chloride under reduced pressure at 30 ℃ to obtain an oily substance, adding 100ml of dichloromethane for dissolving, adding 100ml of saturated sodium chloride solution for washing and extracting, dehydrating an organic layer by using anhydrous magnesium sulfate, evaporating to obtain 12.1g of an oily compound III, wherein the yield is 96%, and the purity is 95% by HPLC (high performance liquid chromatography);
3) preparation of Compound IV from Compound III
Adding 12g of the compound III prepared in the step 2) into a 500ml dry reaction bottle, adding 200ml of dichloromethane, adding 5.3g of 2-ethyl-3-benzofuran, cooling to-5 ℃, stirring for 30min, adding 10g of aluminum trichloride, stirring for reacting for 5h, slowly dropwise adding 100ml of ice water, controlling the internal temperature to be not more than 5 ℃, standing for layering after dropwise adding is finished, removing a water layer, washing an organic layer twice by using 100ml of saturated sodium chloride solution, adding anhydrous magnesium sulfate into the organic layer for dehydration, and evaporating to dryness to obtain an oily compound IV14g, wherein the yield is 91.5%, and the purity is 96% by HPLC (high performance liquid chromatography) detection;
4) preparation of Compound V from Compound IV
Adding 14g of the compound IV obtained in the step 3) into a 500ml reaction bottle, adding 200ml of ethanol and 0.5g of pyridine p-toluenesulfonate, heating to reflux, stirring for reaction for 3 hours, reducing the pressure to 50 ℃ and evaporating the solvent to obtain an oily substance, adding 80ml of dichloroethane, heating to reflux, dissolving, cooling to 7-10 ℃, stirring and crystallizing for 12 hours to obtain a compound V, namely 9.8g of a target product, namely a crude product of benzbromarone, wherein the yield is 83.76%, and the purity is 98% by HPLC detection.
The invention has the beneficial effects that:
the invention takes 3, 5-dibromo-4-hydroxybenzoic acid as a raw material, dihydropyran as a hydroxyl protecting reagent to prepare benzbromarone, and the explored optimized process conditions realize the hydroxyl protection and hydroxyl deprotection of dihydropyran, thereby achieving the purposes of reducing the generation of byproducts in the reaction process, improving the yield and reducing the cost.
Detailed Description
The present invention will be further explained with reference to examples. The following examples are provided only for illustrating the present invention and are not intended to limit the scope of the present invention.
Example 1: preparation of 3, 5-dibromo-4-tetrahydropyranyl ether-benzoic acid (Compound II)
Adding 200ml of dihydropyran, 10g of 3, 5-dibromo-4-hydroxybenzoic acid and 3g of aluminum phosphate into a 500ml reaction bottle, heating to reflux, stirring for reaction for 3 hours, cooling to room temperature, filtering solid aluminum phosphate, distilling off excessive dihydropyran under reduced pressure of 0.01MPa to obtain 12.16g of oily compound II, wherein the yield is 95%, a TLC point plate has no raw material point, and a TLC developing agent is ethyl acetate: n-hexane: acetic acid 4: 1: 0.1.
example 2: preparation of 3, 5-dibromo-4-tetrahydropyranyl ether-benzoyl chloride (Compound III)
Adding 12g of the product obtained in example 1 into a 500ml reaction bottle, adding 200ml of dichloromethane, 1 drop of Dimethylformamide (DMF), 8.17g of N, N-diisopropylethylamine, stirring at 15-20 ℃ for 30min, then dropwise adding 7.5g of thionyl chloride, controlling the dropwise adding speed to be not more than 25 ℃, after the dropwise adding is completed, keeping the temperature at 30-35 ℃ and stirring for reaction for 5h, filtering out hydrochloride of the N, N-diisopropylethylamine, evaporating dichloromethane and excessive thionyl chloride under reduced pressure at 30 ℃ to obtain an oily substance, adding 100ml of dichloromethane to dissolve the oily substance, adding 100ml of saturated sodium chloride solution to wash and extract, dehydrating an organic layer by using anhydrous magnesium sulfate, and evaporating to obtain 12.1g of an oily compound III, wherein the yield is 96%, and the purity is 95% by HPLC detection.
Example 3: preparation of (3, 5-dibromo-4-tetrahydropyranyl ether phenyl) (2-ethyl-3-benzofuranyl) one (Compound IV)
Adding 12g of the compound III prepared in the example 2 into a 500ml dry reaction bottle, adding 200ml of dichloromethane, adding 5.3g of 2-ethyl-3-benzofuran, cooling to-5 ℃, stirring for 30min, adding 10g of aluminum trichloride, stirring for reaction for 5h, slowly dropwise adding 100ml of ice water, controlling the internal temperature to be not more than 5 ℃, standing for layering after dropwise addition, removing an aqueous layer, washing an organic layer twice by using 100ml of saturated sodium chloride solution, adding anhydrous magnesium sulfate into the organic layer for dehydration, and evaporating to dryness to obtain an oily compound IV14g, wherein the yield is 91.5%, and the purity is 96% by HPLC (high performance liquid chromatography).
Example 4: preparation of crude benzbromarone (Compound V)
Adding 14g of the compound IV obtained in the example 3 into a 500ml reaction bottle, adding 300ml of ethanol and 1g of pyridine p-toluenesulfonate (PPTS), heating to 50 ℃, stirring for reaction for 3 hours, reducing the pressure to 50 ℃, evaporating the solvent to dryness to obtain an oily substance, adding 100ml of dichloroethane, heating to reflux for dissolution, cooling to 10 ℃, stirring for crystallization for 12 hours to obtain a compound V, namely 9.4g of a target product, namely a crude product of benzbromarone, wherein the yield is 80.34%, and the purity is 98% by HPLC detection.
Example 5: preparation of crude benzbromarone (Compound V)
14g of compound IV is prepared according to the same steps of the embodiment 1 to the embodiment 3, 200ml of absolute ethyl alcohol and 0.5g of pyridine p-toluenesulfonate (PPTS) are added into a 500ml reaction bottle, the temperature is increased to reflux, stirring is carried out for reaction for 3h, the pressure is reduced to 50 ℃ and the solvent is evaporated to dryness to obtain oily matter, 80ml of dichloroethane is added, the temperature is increased to reflux and dissolution is carried out, the temperature is reduced to 7-10 ℃ and stirring is carried out for crystallization for 12h, and the compound V, namely 9.8g of a target product of benzbromarone crude product, the yield is 83.76%, and the purity is 98% by HPLC detection is obtained.

Claims (7)

1. The method for preparing benzbromarone is characterized by comprising the following preparation routes:
Figure FDA0002488289540000011
2. the method for preparing benzbromarone as claimed in claim 1, wherein the protecting agent and solvent for preparing compound II from compound I are dihydropyrane.
3. The method for preparing benzbromarone as claimed in claim 1, wherein the catalyst for preparing compound IV from compound III is aluminum trichloride.
4. The method for preparing benzbromarone as claimed in claim 1, wherein the solvent for preparing the compound V from the compound IV is ethanol, the catalyst is pyridine p-toluenesulfonate, and the reaction temperature is 50 ℃ to reflux.
5. The method for preparing benzbromarone as claimed in claim 1, wherein a small amount of aluminum phosphate is added as a catalyst in an environment that dihydropyrane is used as a solvent and a protective agent, the mixture is heated to reflux and stirred for reaction for 3 hours, and is subjected to suction filtration, and excessive dihydropyrane is evaporated to dryness to obtain an oily compound II;
then adding dichloromethane into the compound II for dissolving, adding a small amount of dimethylformamide as a catalyst, adding N, N-diisopropylethylamine as an acid-binding agent, dropwise adding thionyl chloride at the temperature of not more than 25 ℃, keeping the temperature of 30-35 ℃ after dropwise adding, stirring for reaction, filtering, evaporating dichloromethane and excessive thionyl chloride to dryness, and purifying to obtain a compound III;
then dissolving the compound III in dichloromethane, adding 2-ethylbenzofuran, adding aluminum trichloride at-5-0 ℃, and carrying out Friedel-crafts acylation reaction and post-treatment to obtain a compound IV;
and then adding the compound IV into ethanol, adding pyridine p-toluenesulfonate as a catalyst, carrying out reflux stirring reaction at 50 ℃ for 3 hours, and carrying out aftertreatment to obtain a compound V.
6. The method for preparing benzbromarone as claimed in claim 1, which comprises the following steps:
1) preparation of compound II from compound I
Adding 200ml of dihydropyrane, 10g of 3, 5-dibromo-4-hydroxybenzoic acid and 3g of aluminum phosphate into a 500ml reaction bottle, heating to reflux, stirring for reaction for 3 hours, cooling to room temperature, filtering off solid aluminum phosphate, distilling off excessive dihydropyrane under reduced pressure of 0.01MPa to obtain 12.16g of an oily compound II, wherein the yield is 95%, and no raw material point exists on a TLC point plate;
2) preparation of compound III from compound II
Adding 12g of the product obtained in the step 1) into a 500ml reaction bottle, adding 200ml of dichloromethane, 1 drop of dimethylformamide, 8.17g of N, N-diisopropylethylamine, stirring at 15-20 ℃ for 30min, then dropwise adding 7.5g of thionyl chloride, controlling the dropwise adding speed to be not more than 25 ℃, after dropwise adding is completed, keeping the temperature at 30-35 ℃ and stirring for reaction for 5h, filtering out hydrochloride of the N, N-diisopropylethylamine, evaporating dichloromethane and excessive thionyl chloride under reduced pressure at 30 ℃ to obtain an oily substance, adding 100ml of dichloromethane for dissolving, adding 100ml of saturated sodium chloride solution for washing and extracting, dehydrating an organic layer by using anhydrous magnesium sulfate, evaporating to obtain 12.1g of an oily compound III, wherein the yield is 96%, and the purity is 95% by HPLC (high performance liquid chromatography);
3) preparation of Compound IV from Compound III
Adding 12g of the compound III prepared in the step 2) into a 500ml dry reaction bottle, adding 200ml of dichloromethane, adding 5.3g of 2-ethyl-3-benzofuran, cooling to-5 ℃, stirring for 30min, adding 10g of aluminum trichloride, stirring for reacting for 5h, slowly dropwise adding 100ml of ice water, controlling the internal temperature to be not more than 5 ℃, standing for layering after dropwise adding is finished, removing a water layer, washing an organic layer twice by using 100ml of saturated sodium chloride solution, adding anhydrous magnesium sulfate into the organic layer for dehydration, and evaporating to dryness to obtain an oily compound IV14g, wherein the yield is 91.5%, and the purity is 96% by HPLC (high performance liquid chromatography) detection;
4) preparation of Compound V from Compound IV
Adding 14g of the compound IV obtained in the step 3) into a 500ml reaction bottle, adding 300ml of ethanol and 1g of pyridine p-toluenesulfonate, heating to 50 ℃, stirring for reaction for 3 hours, reducing the pressure to 50 ℃, evaporating the solvent to dryness to obtain an oily substance, adding 100ml of dichloroethane, heating to reflux for dissolution, cooling to 10 ℃, stirring for crystallization for 12 hours to obtain a compound V, namely 9.4g of a target product, namely a crude product of benzbromarone, wherein the yield is 80.34%, and the purity is 98% by HPLC (high performance liquid chromatography).
7. The method for preparing benzbromarone as claimed in claim 1, which comprises the following steps:
1) preparation of compound II from compound I
Adding 200ml of dihydropyrane, 10g of 3, 5-dibromo-4-hydroxybenzoic acid and 3g of aluminum phosphate into a 500ml reaction bottle, heating to reflux, stirring for reaction for 3 hours, cooling to room temperature, filtering off solid aluminum phosphate, distilling off excessive dihydropyrane under reduced pressure of 0.01MPa to obtain 12.16g of an oily compound II, wherein the yield is 95%, and no raw material point exists on a TLC point plate;
2) preparation of compound III from compound II
Adding 12g of the product obtained in the step 1) into a 500ml reaction bottle, adding 200ml of dichloromethane, 1 drop of dimethylformamide, 8.17g of N, N-diisopropylethylamine, stirring at 15-20 ℃ for 30min, then dropwise adding 7.5g of thionyl chloride, controlling the dropwise adding speed to be not more than 25 ℃, after dropwise adding is completed, keeping the temperature at 30-35 ℃ and stirring for reaction for 5h, filtering out hydrochloride of the N, N-diisopropylethylamine, evaporating dichloromethane and excessive thionyl chloride under reduced pressure at 30 ℃ to obtain an oily substance, adding 100ml of dichloromethane for dissolving, adding 100ml of saturated sodium chloride solution for washing and extracting, dehydrating an organic layer by using anhydrous magnesium sulfate, evaporating to obtain 12.1g of an oily compound III, wherein the yield is 96%, and the purity is 95% by HPLC (high performance liquid chromatography);
3) preparation of Compound IV from Compound III
Adding 12g of the compound III prepared in the step 2) into a 500ml dry reaction bottle, adding 200ml of dichloromethane, adding 5.3g of 2-ethyl-3-benzofuran, cooling to-5 ℃, stirring for 30min, adding 10g of aluminum trichloride, stirring for reacting for 5h, slowly dropwise adding 100ml of ice water, controlling the internal temperature to be not more than 5 ℃, standing for layering after dropwise adding is finished, removing a water layer, washing an organic layer twice by using 100ml of saturated sodium chloride solution, adding anhydrous magnesium sulfate into the organic layer for dehydration, and evaporating to dryness to obtain an oily compound IV14g, wherein the yield is 91.5%, and the purity is 96% by HPLC (high performance liquid chromatography) detection;
4) preparation of Compound V from Compound IV
Adding 14g of the compound IV obtained in the step 3) into a 500ml reaction bottle, adding 200ml of ethanol and 0.5g of pyridine p-toluenesulfonate, heating to reflux, stirring for reaction for 3 hours, reducing the pressure to 50 ℃ and evaporating the solvent to obtain an oily substance, adding 80ml of dichloroethane, heating to reflux, dissolving, cooling to 7-10 ℃, stirring and crystallizing for 12 hours to obtain a compound V, namely 9.8g of a target product, namely a crude product of benzbromarone, wherein the yield is 83.76%, and the purity is 98% by HPLC detection.
CN202010397997.4A 2020-05-12 2020-05-12 Method for preparing benzbromarone Active CN111533718B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202010397997.4A CN111533718B (en) 2020-05-12 2020-05-12 Method for preparing benzbromarone

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202010397997.4A CN111533718B (en) 2020-05-12 2020-05-12 Method for preparing benzbromarone

Publications (2)

Publication Number Publication Date
CN111533718A true CN111533718A (en) 2020-08-14
CN111533718B CN111533718B (en) 2022-05-17

Family

ID=71977699

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202010397997.4A Active CN111533718B (en) 2020-05-12 2020-05-12 Method for preparing benzbromarone

Country Status (1)

Country Link
CN (1) CN111533718B (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115124425A (en) * 2022-06-27 2022-09-30 浙江海昇药业股份有限公司 3, 5-dibromo-4-hydroxybenzoic acid dimer, and synthesis method and application thereof

Citations (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1675154A (en) * 2002-06-07 2005-09-28 科蒂科股份有限公司 Napththalene derivatives which inhibit the cytokine or biological activity of macrophage migration inhibitory factor (MIF)
CN102659727A (en) * 2012-04-20 2012-09-12 东北制药(沈阳)科技发展有限公司 Preparation method of benzbromarone
CN103242271A (en) * 2013-04-11 2013-08-14 宜昌长江药业有限公司 Process for preparing key intermediate 2-ethyl-3-p-hydroxybenzoyl-benzofuran of benzbromarone
CN103242272A (en) * 2013-05-22 2013-08-14 合肥医工医药有限公司 Method for preparing benzbromarone
CN103333143A (en) * 2013-07-05 2013-10-02 昆山龙灯瑞迪制药有限公司 Preparation method of high-purity benzbromarone
EP3075380A1 (en) * 2013-11-28 2016-10-05 Liu, Li Drug for treating vertebrae cervicales and lumber diseases
CN108586402A (en) * 2018-05-15 2018-09-28 石家庄学院 A kind of preparation method of Benzbromarone
US20190218243A1 (en) * 2015-06-03 2019-07-18 Teva Pharmaceuticals International Gmbh Improved processes for the preparation of sofosbuvir and intermediates thereof
US20200062763A1 (en) * 2016-11-16 2020-02-27 Jiangsu Atom Bioscience And Pharmaceutical Co., Ltd. Urat1 inhibitor and use thereof

Patent Citations (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1675154A (en) * 2002-06-07 2005-09-28 科蒂科股份有限公司 Napththalene derivatives which inhibit the cytokine or biological activity of macrophage migration inhibitory factor (MIF)
CN102659727A (en) * 2012-04-20 2012-09-12 东北制药(沈阳)科技发展有限公司 Preparation method of benzbromarone
CN103242271A (en) * 2013-04-11 2013-08-14 宜昌长江药业有限公司 Process for preparing key intermediate 2-ethyl-3-p-hydroxybenzoyl-benzofuran of benzbromarone
CN103242272A (en) * 2013-05-22 2013-08-14 合肥医工医药有限公司 Method for preparing benzbromarone
CN103333143A (en) * 2013-07-05 2013-10-02 昆山龙灯瑞迪制药有限公司 Preparation method of high-purity benzbromarone
EP3075380A1 (en) * 2013-11-28 2016-10-05 Liu, Li Drug for treating vertebrae cervicales and lumber diseases
US20190218243A1 (en) * 2015-06-03 2019-07-18 Teva Pharmaceuticals International Gmbh Improved processes for the preparation of sofosbuvir and intermediates thereof
US20200062763A1 (en) * 2016-11-16 2020-02-27 Jiangsu Atom Bioscience And Pharmaceutical Co., Ltd. Urat1 inhibitor and use thereof
CN108586402A (en) * 2018-05-15 2018-09-28 石家庄学院 A kind of preparation method of Benzbromarone

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
JUAN M. CAMPELO等: "AlPO4 and AlPO4-Al2O3 as New Heterogeneous Catalysts for the Solvent-Free Tetrahydropyranylation of Alcohols and Phenols", 《SYNTHETIC COMMUNICATION》 *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115124425A (en) * 2022-06-27 2022-09-30 浙江海昇药业股份有限公司 3, 5-dibromo-4-hydroxybenzoic acid dimer, and synthesis method and application thereof
CN115124425B (en) * 2022-06-27 2023-10-17 浙江海昇药业股份有限公司 3, 5-dibromo-4-hydroxybenzoic acid dimer, synthesis method and application thereof

Also Published As

Publication number Publication date
CN111533718B (en) 2022-05-17

Similar Documents

Publication Publication Date Title
JP5395908B2 (en) Process for producing 4- (1-hydroxy-1-methylethyl) -2-propylimidazole-5-carboxylic acid ester
CN112661736B (en) Synthetic method of tylosin intermediate
CN111533718B (en) Method for preparing benzbromarone
CN103664912A (en) Synthesis process of prucalopride
CN102395591B (en) Method for preparing prasugrel
CN101037434A (en) Production method of nifuratel
CN111560004A (en) Preparation method of high-purity canagliflozin intermediate
CN102317256B (en) Preparation method for racecadotril
CN101973932B (en) Preparation method of bisacodyl
CN103304550A (en) Preparation method of Olmesartan Medoxomil
CN107298694A (en) The synthetic method and its intermediate of shellfish cholic acid difficult to understand
CN107266304B (en) Novel synthesis method of natural product Salvianolic Acid F
CN111018928B (en) Synthetic method and application of gastrodin hemihydrate
CN103374049B (en) One prepares 5,6, the method for 4 '-trihydroxyflavone-7-0-D-glucuronic acid
CN109438543B (en) Preparation method of high-purity fluticasone furoate
CN107383137A (en) A kind of synthetic method of chenodeoxycholic acid
CN114315575A (en) Preparation method and application of photoinitiator intermediate
CN101928314A (en) Preparation method for capecitabine
CN111362989A (en) Preparation method of Sofosbuvir key intermediate
CN108947831A (en) A kind of purification process of salbutamol intermediate III
CN103923142B (en) Preparation method of roxithromycin intermediate
CN113929649B (en) Preparation method of coriolide derivative
CN102875396A (en) Preparation method of sarpogrelate hydrochloride
CN102351805B (en) Method for preparing, separating and refining 5-amino-1H-tetrazol-1-ylacetic acid
CN111377989B (en) Preparation method of decitabine intermediate

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant
CP01 Change in the name or title of a patent holder

Address after: 317016 coastal industrial zone, Taizhou, Zhejiang, China

Patentee after: Zhejiang Haizhou Pharmaceutical Co.,Ltd.

Address before: 317016 coastal industrial zone, Taizhou, Zhejiang, China

Patentee before: ZHEJIANG HAIZHOU PHARMACEUTICAL CO.,LTD.

CP01 Change in the name or title of a patent holder